| HOPE|| November 4, 1988|
| Food and Drug Administration Act of 1988
Health Professions Reauthorization Act of 1988
National Commission on Acquired Immune Deficiency Syndrome Act
National Institute on Deafness and Other Communication Disorders and Health Research Extension Act of 1988
Nursing Shortage Reduction and Education Extension Act of 1988
Organ Transplant Amendments Act of 1988
Prison Testing Act of 1988|
An Act to amend the Public Health Service Act to establish certain health programs, to revise and extend certain health programs, and for other purposes.
Health Omnibus Extension of 1988
the 100th United States Congress
AIDS amendments of 1988, better known as the Health Omnibus Programs Extension (HOPE) Act of 1988, is a United States statute amending the Public Health Service Act. The Acquired Immune Deficiency Syndrome amendments were compiled as Title II - Programs with Respect to Acquired Immune Deficiency Syndrome within the HOPE Act of 1988. The Title II Act appropriated federal funding for Acquired Immune Deficiency Syndrome education, prevention, research, and testing. The U.S. legislative title provisioned the establishment of the presidentially appointed National Commission on AIDS.
The S. 2889 legislation was passed by the 100th U.S. Congressional session and signed by the 40th President of the United States Ronald Reagan on November 4, 1988.
AIDS amendments of 1988 Wikipedia
The Acquired Immune Deficiency Syndrome was officially recognized on June 5, 1981 when the U.S. Centers for Disease Control and Prevention published a clinical article in the CDC's Morbidity and Mortality Weekly Report. The CDC article acknowledged five young males in the Los Angeles, California area who were infected with the cytomegalovirus and an infrequent form of Pneumocystis Carinii Pneumonia (PCP).
On July 3, 1981, The New York Times published a report concerning forty-one males with scarce cases of Kaposi's sarcoma in California and New York. By the close of 1981, there had been two hundred and seventy cases of severe immune deficiency cases in males across the United States. Of the two hundred and seventy cases, one hundred and twenty-one of those cases resulted in mortality rates in the United States.
On April 13, 1982, the first U.S. congressional hearings were conducted on the Acquired Immune Deficiency Syndrome by U.S. Representative Henry Waxman. By September, U.S. Representatives Phillip Burton and Henry Waxman provided U.S. legislation to fund five million for opportunistic infection surveillance by the Centers for Disease Control and Prevention and ten million for Acquired Immune Deficiency Syndrome research by the National Institutes of Health.
The 1982 U.S. Congressional deliberations concluded on December 17, 1982 when the 97th Congressional session passed the Orphan Drug Act of 1983.
The AIDS amendments established policy for five primary elements with respect to the Acquired Immune Deficiency Syndrome.
Title XXIII - Research with respect to Acquired Immune Deficiency Syndrome established surveyable protocols for clinical research, clinical toxicology, and therapeutic drug monitoring.
Title XXIV - Health services with respect to Acquired Immune Deficiency Syndrome is composed of three segments providing preventive medicine protocols for opportunistic infections.
Title XV - Prevention of Acquired Immune Deficiency Syndrome has two primary parts providing requisites with respect to the prevention of opportunistic infections.